$6.68
00.00%
At close: Jul 2, 4:00 PM EDT
$6.68
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Ocular Therapeutix
OCULNASDAQ
Ocular Therapeutix (NASDAQ:OCUL) Stock, Analyst Ratings, Price Targets, Predictions
Ocular Therapeutix Inc has a consensus price target of $15.5, established from looking at the 43 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, TD Cowen, and Piper Sandler on June 21, 2024, June 20, 2024, and June 14, 2024. With an average price target of $13.67 between Piper Sandler, TD Cowen, and Piper Sandler, there's an implied 104.59% upside for Ocular Therapeutix Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
TD Cowen
Piper Sandler
HC Wainwright & Co.
JMP Securities
1calculated from analyst ratings
Analyst Ratings for Ocular Therapeutix
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/21/2024 | Buy Now | 124.55% | Piper Sandler | Biren Amin | $15 → $15 | Maintains | Overweight | Get Alert |
| 06/20/2024 | Buy Now | 64.67% | TD Cowen | Tara Bancroft | $7 → $11 | Upgrade | Hold → Buy | Get Alert |
| 06/14/2024 | Buy Now | 124.55% | Piper Sandler | Joseph Catanzaro | $15 → $15 | Maintains | Overweight | Get Alert |
| 06/14/2024 | Buy Now | 109.58% | HC Wainwright & Co. | Yi Chen | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2024 | Buy Now | 109.58% | HC Wainwright & Co. | Yi Chen | $16 → $14 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 229.34% | JMP Securities | Jonathan Wolleben | $24 → $22 | Maintains | Market Outperform | Get Alert |
| 05/08/2024 | Buy Now | 4.79% | TD Cowen | Tara Bancroft | $11 → $7 | Maintains | Hold | Get Alert |
| 04/19/2024 | Buy Now | 139.52% | HC Wainwright & Co. | Yi Chen | → $16 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2024 | Buy Now | 259.28% | JMP Securities | Jonathan Wolleben | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | Buy Now | 259.28% | JMP Securities | Jonathan Wolleben | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | Buy Now | 124.55% | HC Wainwright & Co. | Yi Chen | $12 → $15 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 64.67% | TD Cowen | Tara Bancroft | $8 → $11 | Maintains | Market Perform | Get Alert |
| 03/12/2024 | Buy Now | 259.28% | JMP Securities | Jonathan Wolleben | $12 → $24 | Maintains | Market Outperform | Get Alert |
| 02/26/2024 | Buy Now | 124.55% | Piper Sandler | Joseph Catanzaro | $10 → $15 | Maintains | Overweight | Get Alert |
| 02/14/2024 | Buy Now | 79.64% | HC Wainwright & Co. | Yi Chen | → $12 | Reiterates | Buy → Buy | Get Alert |
| 02/09/2024 | Buy Now | 124.55% | B of A Securities | Tazeen Ahmad | → $15 | Initiates | → Buy | Get Alert |
| 10/04/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Yi Chen | → $12 | Reiterates | Buy → Buy | Get Alert |
| 09/14/2023 | Buy Now | 169.46% | Baird | Colleen Kusy | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Yi Chen | → $12 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2023 | Buy Now | 79.64% | Baird | Colleen Kusy | $10 → $12 | Maintains | Outperform | Get Alert |
| 06/13/2023 | Buy Now | 79.64% | JMP Securities | Jonathan Wolleben | → $12 | Reiterates | → Market Outperform | Get Alert |
| 06/13/2023 | Buy Now | 79.64% | HC Wainwright & Co. | Yi Chen | $10 → $12 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | 49.7% | HC Wainwright & Co. | Yi Chen | $11 → $10 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | 79.64% | JMP Securities | Jonathan Wolleben | $11 → $12 | Maintains | Outperform | Get Alert |
| 04/21/2023 | Buy Now | 169.46% | Baird | Colleen Kusy | → $18 | Initiates | → Outperform | Get Alert |
| 03/07/2023 | Buy Now | 64.67% | HC Wainwright & Co. | Yi Chen | → $11 | Reiterates | → Buy | Get Alert |
| 03/07/2023 | Buy Now | 64.67% | JMP Securities | Jonathan Wolleben | $12 → $11 | Maintains | Market Outperform | Get Alert |
| 02/14/2023 | Buy Now | 64.67% | HC Wainwright & Co. | Yi Chen | $9 → $11 | Maintains | Buy | Get Alert |
| 02/13/2023 | Buy Now | 79.64% | JMP Securities | Jonathan Wolleben | → $12 | Reiterates | → Market Outperform | Get Alert |
| 01/09/2023 | Buy Now | 79.64% | JMP Securities | Jonathan Wolleben | $25 → $12 | Maintains | Market Outperform | Get Alert |
| 11/08/2022 | Buy Now | 34.73% | HC Wainwright & Co. | Yi Chen | $10 → $9 | Maintains | Buy | Get Alert |
| 11/08/2022 | Buy Now | 109.58% | Raymond James | Dane Leone | $29 → $14 | Maintains | Strong Buy | Get Alert |
| 08/09/2022 | Buy Now | 274.25% | JMP Securities | Jonathan Wolleben | $20 → $25 | Maintains | Market Outperform | Get Alert |
| 05/10/2022 | Buy Now | 199.4% | JMP Securities | Jonathan Wolleben | $22 → $20 | Maintains | Market Outperform | Get Alert |
| 05/10/2022 | Buy Now | 49.7% | HC Wainwright & Co. | Yi Chen | $14 → $10 | Maintains | Buy | Get Alert |
| 05/10/2022 | Buy Now | 139.52% | Piper Sandler | Joseph Catanzaro | $20 → $16 | Maintains | Overweight | Get Alert |
| 03/01/2022 | Buy Now | 229.34% | JMP Securities | Jonathan Wolleben | $30 → $22 | Maintains | Market Outperform | Get Alert |
| 11/09/2021 | Buy Now | 349.1% | JMP Securities | Jonathan Wolleben | — | Maintains | Market Outperform | Get Alert |
| 10/25/2021 | Buy Now | 109.58% | HC Wainwright & Co. | Yi Chen | — | Maintains | Buy | Get Alert |
| 10/18/2021 | Buy Now | 334.13% | Raymond James | Dane Leone | — | Maintains | Strong Buy | Get Alert |
| 10/12/2021 | Buy Now | 169.46% | HC Wainwright & Co. | Yi Chen | — | Maintains | Buy | Get Alert |
| 09/09/2021 | Buy Now | 394.01% | JMP Securities | Jonathan Wolleben | — | Maintains | Market Outperform | Get Alert |
| 08/10/2021 | Buy Now | 154.49% | HC Wainwright & Co. | Yi Chen | — | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for Ocular Therapeutix (OCUL) stock?
The latest price target for Ocular Therapeutix (NASDAQ:OCUL) was reported by Piper Sandler on June 21, 2024. The analyst firm set a price target for $15.00 expecting OCUL to rise to within 12 months (a possible 124.55% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ocular Therapeutix (OCUL)?
The latest analyst rating for Ocular Therapeutix (NASDAQ:OCUL) was provided by Piper Sandler, and Ocular Therapeutix maintained their overweight rating.
When was the last upgrade for Ocular Therapeutix (OCUL)?
The last upgrade for Ocular Therapeutix Inc happened on June 20, 2024 when TD Cowen raised their price target to $11. TD Cowen previously had a hold for Ocular Therapeutix Inc.
When was the last downgrade for Ocular Therapeutix (OCUL)?
There is no last downgrade for Ocular Therapeutix.
When is the next analyst rating going to be posted or updated for Ocular Therapeutix (OCUL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocular Therapeutix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocular Therapeutix was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
Is the Analyst Rating Ocular Therapeutix (OCUL) correct?
While ratings are subjective and will change, the latest Ocular Therapeutix (OCUL) rating was a maintained with a price target of $15.00 to $15.00. The current price Ocular Therapeutix (OCUL) is trading at is $6.68, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.